Court dismisses portion of Eli Lilly lawsuit against Empower Pharmacy, leaves some claims alive
A federal judge ruled that part of Eli Lilly's lawsuit against Empower Pharmacy is dismissed. The suit alleged that Empower misled patients about its compounded versions of tirzepatide, an obesity treatment.
The dismissal covers claims that Empower's labeling or marketing was deceptive. However, the court indicated that other allegations, particularly those concerning whether Empower's compounded product meets certain standards, may continue.
The decision means the litigation will proceed on a narrower set of issues, leaving Lilly to pursue those remaining claims in court.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Court dismisses part of Lilly lawsuit against Empower, some claims can proceed”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that